Muscular Disorder TRIZ Cases

Amniotic membrane scaffolds enable infected wound treatment by providing antimicrobial barriers while stimulating endogenous repair mechanisms.

A tenocyte-seeded bioscaffold promotes tissue integration and healing in rotator cuff repair applications.

FORTETROPIN egg yolk powder activates the mTOR pathway to increase muscle protein synthesis, avoiding testosterone side effects.

Lycium barbarum glycopeptide replaces riluzole to extend survival and reduce inflammation in amyotrophic lateral sclerosis.

Merges splicing modulators, stabilizers, and enhancers into one composition to overcome insufficient single-agent efficacy in spinal muscular atrophy treatment.

Hypoxia-cultured mesenchymal stem cells promote cartilage regeneration while preventing osteoarthritis progression.

CFTR correctors rescue alpha-sarcoglycan and SERCA1 function, addressing liver toxicity risks from dantrolene.

Specific antibodies inhibit GDF-15 signaling to suppress cancer cell proliferation.

A suspension seed process produces recombinant AAV vectors in mammalian cells.

Administering IL-17 antagonists alongside regenerative therapies reduces fibrosis and restores tissue repair capacity in aged subjects.

Esterified ketone bodies increase blood hydroxybutyrate levels while eliminating gastric discomfort from large oral volumes.

A biocompatible porous matrix releases PDGF within 24 hours to resolve poor healing and high failure rates in tendon repairs.

Kinase inhibitors reduce DUX4 expression in muscle cells to treat facioscapulohumeral muscular dystrophy.

Amino acid substitutions in the Fc region of anti-VLA-4 antibodies reduce adverse effector function and improve stability, addressing rapid clearance issues.

An anti-myostatin antibody binds latent myostatin to increase muscle mass and strength.

RARγ agonists reduce scar tissue formation and increase myosin heavy chain levels to restore muscle function.

Natural Dipsacus and Cynanchum extracts boost physical performance without steroid side effects.

A calcium ionic compound with ascorbic acid and branched-chain amino acids regulates energy metabolism to inhibit muscle degradation.

Engineered anti-transferrin receptor antibodies utilize specific variable heavy and light chain regions to bind target proteins.

Beta-hydroxy-beta-methylbutyrate supplementation accelerates muscle healing and strength restoration following soft tissue trauma.

Targeted RNA interference suppresses RPS25 gene expression to address the lack of disease-modifying therapies for C9orf72 ALS and Huntington-like syndromes.

Bone marrow-derived extracellular vesicles protect diaphragm muscle fibers from mechanical ventilation damage.

Zilucoplan inhibits C5 cleavage to prevent membrane attack complex formation, reducing tissue damage and improving muscle strength in myasthenia gravis.

Phage display pre-selection and targeted co-administration reduce immunization duration while maintaining high specificity for autoimmune disease treatments.

Phosphorodiamidate morpholino oligonucleotides hybridize to utrophin mRNA 3'UTR sequences to inhibit Let-7c microRNA binding.

Phenoxybenzoic acid derivatives upregulate Notch signaling to treat malignancies resistant to standard inhibitors.

A short-hairpin RNA construct targets the ORAI1 calcium channel to reduce protein expression in skeletal muscle tissue.

ADP ribosyl cyclase antagonist compounds inhibit calcium channels to prevent muscle necrosis and inflammation without the side effects of glucocorticoids.

S1P inhibiting agents reduce sphingosine-1-phosphate levels to enhance fatty acid oxidation and exercise tolerance without requiring physical training.

Exosome-based therapy bypasses stem cell senescence and donor variability while reducing immune rejection risks.

Segmented dosing schedules stabilize plasma concentrations to enhance gait while minimizing CNS side effects and sleep disturbances.

Beta-hydroxy beta-methylbutyrate supplementation promotes isoprenoid production to counteract statin-induced myopathy and preserve lipid-lowering efficacy.

Peptide nucleic acid inhibits miR-96-5p via complementary binding, resisting nucleases to maintain intraneuronal glutathione levels.

Combining bioavailable silicon with magnesium treats recurrent muscle cramps without serious side effects.

Replacing sugar with herbal extracts sustains energy delivery while improving protein synthesis to treat sarcopenia without health risks.

Inebilizumab depletes CD19+ B cells to reduce autoantibody production, addressing slow onset and limited durability of standard immunosuppressive therapies.

Intact bovine milk-derived exosomes deliver bioactive cargo to target cells, enhancing maximal and spare respiratory capacity.

TGF-beta and heparin guide skeletal muscle-derived cells to become contractile induced smooth muscle cells, resolving proliferation limits of primary sources.

D2 inhibitor compounds prevent muscle atrophy and enhance skin tissue regeneration by blocking thyroid hormone-mediated catabolism.

Specific oxime and alkoxy derivatives inhibit myostatin gene expression to promote muscle growth.

Selecting adult cardiac stem cells with specific marker profiles prevents tumour formation while promoting cardio-protection.